A microfluidic platform for cultivating ovarian cancer spheroids and testing their responses to chemotherapies
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
There is increasing interest in utilizing in vitro cultures as patient avatars to develop personalized treatment for cancer. Typical cultures utilize Matrigel-coated plates and media to promote the proliferation of cancer cells as spheroids or tumor explants. However, standard culture conditions operate in large volumes and require a high concentration of cancer cells to initiate this process. Other limitations include variability in the ability to successfully establish a stable line and inconsistency in the dimensions of these microcancers for in vivo drug response measurements. This paper explored the utility of microfluidics in the cultivation of cancer cell spheroids. Six patient-derived xenograft (PDX) tumors of high-grade serous ovarian cancer were used as the source material to demonstrate that viability and epithelial marker expression in the microfluidic cultures was superior to that of Matrigel or large volume 3D cultures. To further demonstrate the potential for miniaturization and multiplexing, we fabricated multichamber microfluidic devices with integrated microvalves to enable serial seeding of several chambers followed by parallel testing of several drug concentrations. These valve-enabled microfluidic devices permitted the formation of spheroids and testing of seven drug concentrations with as few as 100,000 cancer cells per device. Overall, we demonstrate the feasibility of maintaining difficul-to-culture primary cancer cells and testing drugs in a microfluidic device. This microfluidic platform may be ideal for drug testing and personalized therapy when tumor material is limited, such as following the acquisition of biopsy specimens obtained by fine-needle aspiration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Spheroids represent a useful tool for maintaining patient-specific tumors in vitro and functional and genomic similarities between primary serous OC tumor tissue or ascites and matched spheroids have been shown (Dadgar et al., 2020; Marrella, 2020; Velletri et al., 2022).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Dadgar et al., 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“| Ovarian | Dadgar et al. (2020) | • Single chamber with 19 microwells | PDX tumors of the HGSOC type | Superior spheroid formation and viability compared to large volume 3D cultures |”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Dadgar et al., 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“| Ovarian | Dadgar et al. (2020) | • Multi-chamber with 8 chambers | PDX tumors of the HGSOC type | Superior spheroid formation and viability compared to large volume 3D cultures |”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Dadgar et al., 2020
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Dadgar et al. incorporated multiple patient-derived xenograft (PDX) tumors of the HGSOC subtype into microfluidic devices, where they observed enhanced spheroid formation, proliferation, and viability under microfluidic conditions compared to larger-scale 3D cultures or Matrigel (Dadgar et al., 2020).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Dadgar et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“Subsequently, the researchers used a multi-chamber microfluidic device, which allowed for serial seeding of chambers and independent, parallel perfusion, in order to test the response of each PDX spheroid to doxorubicin and gemcitabine.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Dadgar et al., 2020
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Organoid models of human and mouse ductal pancreatic cancer
Boj, S. F., Hwang, C.-I., Baker, L. A., Chio, I. I. C., Engle, D. D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M. S., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.021 · Cited by 2,150
Ozols, R. F., Bundy, B. N., Greer, B. E., Fowler, J. M., Clarke-Pearson, D., Burger, R. A., Mannel, R. S., DeGeest, K., Hartenbach, E. M., & Baergen, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.153 · Cited by 2,032
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Mehta, G., Hsiao, A. Y., Ingram, M., Luker, G. D., & Takayama, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.045 · Cited by 1,172
Spherical Cancer Models in Tumor Biology
Weiswald, L.-B., Bellet, D., & Dangles-Marie, V. (2015) · Neoplasia · doi:10.1016/j.neo.2014.12.004 · Cited by 1,141
Three-dimensional culture systems in cancer research: Focus on tumor spheroid model
Nath, S., & Devi, G. R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.013 · Cited by 919
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity
Kopper, O., de Witte, C. J., Lõhmussaar, K., Valle-Inclan, J. E., Hami, N., Kester, L., Balgobind, A. V., Korving, J., Proost, N., Begthel, H., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0422-6 · Cited by 834
Huang, L., Holtzinger, A., Jagan, I., BeGora, M., Lohse, I., Ngai, N., Nostro, C., Wang, R., Muthuswamy, L. B., Crawford, H. C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3973 · Cited by 740
Spheroid Culture System Methods and Applications for Mesenchymal Stem Cells
Ryu, N.-E., Lee, S.-H., & Park, H. (2019) · Cells · doi:10.3390/cells8121620 · Cited by 517
Advances in multicellular spheroids formation
Cui, X., Hartanto, Y., & Zhang, H. (2017) · Journal of The Royal Society Interface · doi:10.1098/rsif.2016.0877 · Cited by 508
Cited by
Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment
Schoutrop, E., Moyano-Galceran, L., Lheureux, S., Mattsson, J., Lehti, K., Dahlstrand, H., & Magalhaes, I. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.027 · Cited by 176
3D cancer models: One step closer to in vitro human studies
Manduca, N., Maccafeo, E., Maria, R. D., Sistigu, A., & Musella, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1175503 · Cited by 109
Tosca, E. M., Ronchi, D., Facciolo, D., & Magni, P. (2023) · Biomedicines · doi:10.3390/biomedicines11041058 · Cited by 103
Modelling the complex nature of the tumor microenvironment: 3D tumor spheroids as an evolving tool
Rodrigues, D. B., Reis, R. L., & Pirraco, R. P. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-00997-9 · Cited by 94
Spheroids in cancer research: Recent advances and opportunities
Arora, S., Singh, S., Mittal, A. K., Desai, N., Khatri, D. K., Gugulothu, D. B., Lather, V., Pandita, D., & Vora, L. K. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106033 · Cited by 92
Metadata
- Authors
- Dadgar, N., Gonzalez-Suarez, A. M., Fattahi, P., Hou, X., Weroha, J. S., Gaspar-Maia, A., Stybayeva, G., & Revzin, A.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Stybayeva, Gulnaz
- Revzin, Alexander
- ORCID
- Venue
- Microsystems & Nanoengineering
- Published
- 2020-10-19
- Volume
- 6
- Issue
- 1
- Pages
- 93-93
- ISSN
- 2055-7434 (ISSN-L)
- PMC
- PMC8433468
- OpenAlex
- W3094421561
- Cited by
- 99
- References
- 42
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 25 · 2023: 23 · 2022: 15 · 2021: 11
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Microsystems & Nanoengineering (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic (P50- CA136393, CA136393)
- National Institutes of Health (CA136393)
- National Cancer Institute (R21CA236612, P50CA136393)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Bio-sensing Technologies
- Keywords
- microfluidics, cancer cell spheroids, high-grade serous ovarian cancer, patient-derived xenografts, precision oncology, microvalves, fine-needle aspiration, 3D cell culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A microfluidic platform for cultivating ovarian cancer spheroids and testing their responses to chemotherapies. https://app.cochat.ai/papers/10.1038/s41378-020-00201-6
- The paper
- Dadgar, N., Gonzalez-Suarez, A. M., Fattahi, P., Hou, X., Weroha, J. S., Gaspar-Maia, A., Stybayeva, G., & Revzin, A. (2020). A microfluidic platform for cultivating ovarian cancer spheroids and testing their responses to chemotherapies. Microsystems & Nanoengineering. https://doi.org/10.1038/s41378-020-00201-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.